Publications & Presentations


ARM fosters investment, research & development, commercialization, and access to safe, effective, and transformational treatments and cures.


ARM fosters investment, research & development, commercialization, and access to safe, effective, and transformational treatments and cures.

Recent Presentations

MOST RECENT PRESENTATION
July 28, 2020

The Art of Gene Therapy Summit

Virtual

Janet Lambert, CEO, ARM

The presentation provides a preview of the trends and metrics that will be examined in ARM’s upcoming H1 2020 report.

May 11, 2020

Valuing Transformative Therapies

Virtual

Janet Lambert, CEO, ARM

The presentation, which provides an overview on value demonstration for cell and gene therapies, cites information from ARM’s library of original policy analyses.

Download Presentation  
February 27, 2020

Landscape and Evolution of the Cell & Gene Therapy Marketplace

New York City

Janet Lambert, CEO, ARM

The presentation, which provides an overview of public policy considerations for the cell and gene therapy sector, cites information from ARM’s library of original policy analyses.

Download Presentation  

Recent Publications

MOST RECENT PUBLICATION
June 18, 2020

A Wave of New Technology: Gene-Edited Therapies Produce First Clinical Data

May 5, 2020
February 28, 2020

Recent Webinars

MOST RECENT WEBINAR
October 24, 2017

CAR-T Approval: What’s Next?

CAR-T cell therapy is now approved in the U.S. The first product, Novartis’ Kymriah, is approved to treat pediatric and young adult patients with B-cell acute lymphoblastic lymphoma, and products for other oncological indications are hot on its heels. Join Informa Pharma Intelligence and ARM for an interactive webinar to explore what this historic approval means for the patient community, as well as how this sector will approach the scientific, clinical, policy and business issues surrounding CAR-T approvals.

May 27, 2020
May 21, 2020

Recently Submitted Comments, Letters, Statements

March 2020